在尿癌中抑制FGFR
Roger Li1, Joshua Linscott2, James W F Catto3
1Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
European urology
|October 1, 2024
概括
2024年FDA对herdafitinib的批准标志着针对性膀癌症治疗的新时代. FGFR抑制剂在治疗尿路细胞癌方面表现有前途,目前正在对早期应用进行研究.
科学领域:
- 纤维细胞生长因子受体 (FGFR) 路径在瘤发生过程中的改变.
- 膀癌中的FGFR3变化,包括患病率和预后意义.
背景情况:
- 2024年FDA批准的erdafitinib用于转移性尿路细胞癌 (mUC) 与FGFR3变化.
- FGFR路径的改变驱动膀癌的瘤发生,导致细胞增殖.
研究的目的:
- 审查FGFR通路改变在膀癌中的影响.
- 总结支持FGFR抑制剂在mUC管理中的临床数据.
- 讨论FGFR抑制在膀癌治疗中的剩余挑战和未来方向.
主要方法:
- 在PubMed和MEDLINE (1995-2024) 系统的文献搜索FGFR抑制剂在泌尿器癌.
- 使用的关键词:"FGFR"和"膀癌".
- 由国际专家小组合成的合作叙事评论.
主要成果:
- 在70%的低度非肌肉侵入性膀癌中发现了体质FGFR3变化.
- FGFR3的变化激活下游信号,促进细胞增殖.
- 改变FGFR3的瘤可能具有非炎症的微环境,对免疫疗法反应没有明显的影响.
- 在mUC中研究的泛FGFR抑制剂;静脉输送系统显示出早期UC的潜力.
结论:
- 抑制FGFR即将改变膀癌的治疗方法.
- 了解膀癌生物学,诊断和药物输送方面的进展将推动精准医学.
- 预计FGFR抑制将导致膀癌精确治疗的进步.
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Glomerular Filtration Rate and its Regulation
2.3K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.3K


